Plasmodium falciparum apicoplast ribosome 50S subunit (PfApicoplast 50S)

The Plasmodium falciparum apicoplast ribosome 50S subunit is a critical component of the protein translation machinery within the apicoplast, a non-photosynthetic plastid organelle essential for the parasite's survival (Royal Society Publishing, 2014; NIH, 2016). Derived from an ancient cyanobacterial endosymbiont, this ribosome is prokaryotic in nature, making it a distinct therapeutic target from the eukaryotic ribosomes of the human host (Portland Press, 2018; NIH, 2004). It is responsible for synthesizing essential proteins encoded by the apicoplast genome, which are vital for the organelle's maintenance and metabolic functions, such as isoprenoid biosynthesis (NIH, 2022; bioRxiv, 2024). Several classes of antibiotics, including macrolides like azithromycin and lincosamides like clindamycin, exert their antimalarial effects by binding to the 50S subunit, thereby inhibiting protein synthesis (ASM, 2007; NIH, 2025). A hallmark of drugs targeting this subunit is the "delayed death" phenomenon, where the parasite completes its current life cycle but its progeny fail to survive due to the loss of functional apicoplasts (Portland Press, 2018; ASM, 2007). Resistance to these drugs often arises through mutations in the 23S ribosomal RNA or ribosomal proteins such as L4 (NIH, 2025; NIH, 2007). This target is particularly attractive for drug development because its bacterial-like structure allows for high selectivity, minimizing off-target effects on human cells (NIH, 2016; NIH, 2004). However, the slow onset of action associated with apicoplast inhibition necessitates the use of these drugs in combination with faster-acting antimalarials (Portland Press, 2018).

Other names

Apicoplast large ribosomal subunitApicoplast LSU50S ribosomal subunit of the apicoplastPlasmodium falciparum 50S apicoplast ribosome

Inhibition of protein synthesis by binding to the 50S ribosomal subunit, specifically at the peptidyl transferase center or the peptide exit tunnel, which blocks the elongation of nascent polypeptide chains (Sidhu et al., 2007; Dahl & Rosenthal, 2007).